Okey Stephanie 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Jun 18, 2026
Research Summary
AI-generated summary of this filing
Crinetics (CRNX) Director Stephanie Okey Sells 6,900 Shares
What Happened Stephanie Okey, a director of Crinetics Pharmaceuticals (CRNX), sold a total of 6,900 shares in two open-market transactions on June 17, 2026. She sold 6,292 shares at a volume-weighted average price (VWAP) of $35.62 for proceeds of $224,121, and 608 shares at a VWAP of $36.22 for proceeds of $22,022 — total proceeds ≈ $246,143. These sales were reported on Form 4 filed June 18, 2026.
Key Details
- Transaction date: June 17, 2026; Form 4 filed: June 18, 2026 (timely filing).
- Trades: two open-market sales (reporting code S).
- 6,292 shares at VWAP $35.62 (range $35.19–$36.06) — $224,121 (F2).
- 608 shares at VWAP $36.22 (range $36.19–$36.29) — $22,022 (F3).
- Total shares sold: 6,900; total proceeds ≈ $246,143.
- Footnote: Sales were effected automatically under a Rule 10b5-1 trading plan adopted Nov 19, 2025 (F1).
- Shares owned after the transaction: not specified in the provided filing; consult the full Form 4 or issuer for updated holdings.
Context These were sales, not purchases; sales executed under a pre-established 10b5-1 plan are typically routine and do not by themselves indicate a change in the insider's view of the company. No option exercises, gifts, or tax-withholding events were reported in this filing.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-06-17$35.62/sh−6,292$224,121→ 7,008 total - Sale
Common Stock
[F1][F3]2026-06-17$36.22/sh−608$22,022→ 6,400 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
- [F2]The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sale price of $35.62 per share. The range of sale prices on the transaction date was $35.19 to $36.06. Detailed information on the exact number of shares can be obtained from the Issuer upon request.
- [F3]The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sale price of $36.22 per share. The range of sale prices on the transaction date was $36.19 to $36.29. Detailed information on the exact number of shares can be obtained from the Issuer upon request.